CUE BIOPHARMA INC's ticker is and the CUSIP is 22978P906. A total of 3 filers reported holding CUE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114 | -75.0% | 49,700 | -60.3% | 0.00% | – |
| Q2 2023 | $456 | +516.2% | 125,100 | +501.4% | 0.00% | – |
| Q1 2023 | $74 | 0.0% | 20,800 | -20.3% | 0.00% | – |
| Q4 2022 | $74 | -99.2% | 26,100 | +536.6% | 0.00% | – |
| Q3 2022 | $9,000 | -67.9% | 4,100 | -64.7% | 0.00% | – |
| Q2 2022 | $28,000 | -83.9% | 11,600 | -67.6% | 0.00% | – |
| Q1 2022 | $174,000 | +461.3% | 35,800 | +1178.6% | 0.00% | – |
| Q4 2021 | $31,000 | -83.3% | 2,800 | -81.6% | 0.00% | – |
| Q3 2021 | $186,000 | +8.8% | 15,200 | +3.4% | 0.00% | – |
| Q2 2021 | $171,000 | +584.0% | 14,700 | +69900.0% | 0.00% | – |
| Q1 2021 | $25,000 | +1150.0% | 21 | +950.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 2 | +100.0% | 0.00% | – |
| Q3 2020 | $1,000 | -95.8% | 1 | -90.0% | 0.00% | – |
| Q2 2020 | $24,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 29,100 | $66,930 | 0.00% |
| SIMPLEX TRADING, LLC | 49,700 | $114 | 0.00% |